Plain-English translation of NCT06538337 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The HERA trial is testing a newer approach to radiation therapy called hypofractionated stereotactic body radiation therapy (SBRT) for patients with endometrial or cervical cancer who have already had surgery. Instead of traditional radiation spread over many weeks, this treatment delivers the same total dose in just 5 sessions over about 2 weeks, using advanced imaging to adjust the beam in real time for each session.
Standard radiation therapy for gynecologic cancer requires many treatments over several weeks, which can be inconvenient and may cause side effects. Research in other cancers has shown that this newer, faster approach with real-time imaging guidance may be just as effective while reducing side effects and treatment burden.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will first have planning scans (CT or MRI) to map out your treatment. Then you will receive 5 radiation therapy sessions, each about a week apart (every other day, excluding weekends). Each session takes about 30 minutes. After treatment ends, you will see your doctor within 3 months, and then every 6 months for 5 years to check how you're doing and watch for any side effects.
AI-generated summary from trial data · Sep 2, 2026 · Not medical advice
United States